Get the Stockscreener App
1.4706
0.64%
-0.0094
Mira Pharmaceuticals Inc stock is traded at $1.4706, with a volume of 49,768.
It is down -0.64% in the last 24 hours and up +2.12% over the past month.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
See More
Previous Close:
$1.48
Open:
$1.49
24h Volume:
49,768
Relative Volume:
0.02
Market Cap:
$61.58M
Revenue:
-
Net Income/Loss:
$-11.24M
P/E Ratio:
-1.9312
EPS:
-0.7615
Net Cash Flow:
$-4.79M
1W Performance:
-2.61%
1M Performance:
+2.12%
6M Performance:
+30.14%
1Y Performance:
+10.57%
1-Day Range:
$1.46
$1.50
1-Week Range:
$1.44
$1.51
52-Week Range:
$0.73
$2.45
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Name
Mira Pharmaceuticals Inc
Sector
Industry
Phone
813-369-5150
Address
1200 BRICKELL AVENUE, MIAMI
Compare MIRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.4706 | 61.98M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
1,081.76 | 991.76B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
205.77 | 499.90B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
224.51 | 412.54B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
MRK
Merck Co Inc
|
109.85 | 269.55B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
NVS
Novartis Ag Adr
|
141.53 | 272.43B | 54.45B | 14.42B | 17.15B | 7.333 |
Mira Pharmaceuticals Inc Stock (MIRA) Latest News
MIRA Pharmaceuticals Inc. (MIRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Quarterly Risk: Will MIRA Pharmaceuticals Inc stock gain from strong economyJobs Report & Real-Time Buy Signal Alerts - moha.gov.vn
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Update - MarketBeat
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog - York Dispatch
Mira Pharmaceuticals approves CEO incentive awards including SKNY acquisition bonus By Investing.com - Investing.com South Africa
Mira Pharmaceuticals approves CEO incentive awards including SKNY acquisition bonus - Investing.com
Will MIRA Pharmaceuticals Inc. stock gain from strong economyJuly 2025 Recap & Fast Moving Stock Trade Plans - Bölüm Sonu Canavarı
Is MIRA Pharmaceuticals Inc. stock a safe investment in uncertain markets2025 Price Targets & Fast Entry Momentum Trade Alerts - Улправда
Will MIRA Pharmaceuticals Inc. stock maintain dividend yieldLong Setup & Daily Growth Stock Investment Tips - DonanımHaber
MIRA Pharmaceuticals (MIRA) details 2025 CEO bonuses and equity awards - Stock Titan
Can MIRA Pharmaceuticals Inc. stock beat analyst upgradesOptions Play & Weekly Setup with ROI Potential - Улправда
Is MIRA Pharmaceuticals Inc. stock attractive for growth ETFsMarket Performance Recap & Technical Pattern Alert System - Улправда
MIRA Pharmaceuticals (NASDAQ:MIRA) Trading Up 2.1% – Here’s What Happened - Defense World
MIRA Pharmaceuticals (NASDAQ:MIRA) Trading Up 2.1%Here's What Happened - MarketBeat
MIRA Pharmaceuticals expands stock offering by $15M - MSN
Mira Pharmaceuticals increases at-the-market offering by $15.2 million - Investing.com Canada
MIRA Pharmaceuticals Expands Stock Offering by $15M - TipRanks
MIRA Pharmaceuticals Increases Stock Offering Limit - TradingView — Track All Markets
Mira Pharmaceuticals (MIRA) Stock Analysis Report | Financials & Insights - Benzinga
How MIRA Pharmaceuticals Inc. stock performs in rising dollar environmentTrade Ideas & Verified Technical Signals - Newser
Why MIRA Pharmaceuticals Inc. stock is seen as undervaluedJuly 2025 Review & Daily Technical Forecast Reports - Newser
Is MIRA Pharmaceuticals Inc. stock attractive for passive investorsTrade Volume Summary & Fast Exit and Entry Trade Guides - Newser
Why MIRA Pharmaceuticals Inc. stock remains on watchlistsAnalyst Upgrade & Scalable Portfolio Growth Methods - Newser
MIRA Pharmaceuticals (NASDAQ:MIRA) and Annovis Bio (NYSE:ANVS) Critical Analysis - Defense World
Telomir and Mira Pharmaceuticals advance through key development milestones with Recipharm support - marketscreener.com
MIRA Pharmaceuticals (NASDAQ:MIRA) Rating Lowered to Sell at Wall Street Zen - MarketBeat
What risks investors should watch in MIRA Pharmaceuticals Inc. stockQuarterly Earnings Report & Real-Time Volume Analysis - newser.com
Will MIRA Pharmaceuticals Inc. stock see PE expansionProfit Target & Trade Opportunity Analysis - newser.com
What high frequency data says about MIRA Pharmaceuticals Inc.Weekly Market Outlook & Fast Exit and Entry Trade Guides - newser.com
Why MIRA Pharmaceuticals Inc. stock is favored by pension funds2025 Historical Comparison & Fast Gain Stock Trading Tips - newser.com
Is MIRA Pharmaceuticals Inc. stock trading near support levelsJuly 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Will MIRA Pharmaceuticals Inc. stock maintain growth storyJuly 2025 Momentum & Fast Entry High Yield Stock Tips - newser.com
Is MIRA Pharmaceuticals Inc. showing signs of accumulationMarket Growth Report & Long-Term Capital Growth Ideas - newser.com
Will MIRA Pharmaceuticals Inc. continue its uptrendDip Buying & Smart Allocation Stock Reports - newser.com
Should you wait for a breakout in MIRA Pharmaceuticals Inc.July 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Will MIRA Pharmaceuticals Inc. stock benefit from sector rotation2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - newser.com
Applying big data sentiment scoring on MIRA Pharmaceuticals Inc.Earnings Miss & Long-Term Growth Stock Strategies - newser.com
Mira Pharmaceuticals Inc Stock (MIRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.70%
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):